Common use of Pfizer GCP Training Clause in Contracts

Pfizer GCP Training. Prior to enrollment of any Study Subjects (as defined in Section 4, Subject Enrollment), Principal Investigator and any sub- investigators will complete the Pfizer-provided Good Clinical Practice training course (“Pfizer GCP Training”). Any investigators who later join the Study will complete the Pfizer GCP Training before performing Study-related duties. For studies of applicable duration, Principal Investigator and sub- investigators will complete Pfizer GCP Training every three years during the term of the Study, or more often if there are significant changes to the ICH GCP guidelines or course materials.

Pfizer GCP Training. Prior to enrollment of any Study Subjects (as defined in Section 4, Subject Enrollment), Principal Investigator and any sub- sub-investigators will complete the Pfizer-provided Good Clinical Practice training course (“Pfizer GCP Training”). Any investigators who later join the Study will complete the Pfizer GCP Training before performing Study-related duties. For studies of applicable duration, Principal Investigator and sub- sub-investigators will complete Pfizer GCP Training every three years during the term of the Study, or more often if there are significant changes to the ICH GCP guidelines or course materials.

Pfizer GCP Training. Prior to enrollment of any Study Subjects (as defined in Section 4, Subject Enrollment), Principal Investigator and any sub- sub-investigators will complete the Pfizer-provided Good Clinical Practice training course (“Pfizer GCP Training”). Any investigators who later join the Study will complete the Pfizer GCP Training before performing Study-Study- related duties. For studies of applicable duration, Principal Investigator and sub- sub-investigators will complete Pfizer GCP Training every three years during the term of the Study, or more often if there are significant changes to the ICH GCP guidelines or course materials.are

Pfizer GCP Training. Prior to enrollment of any Study Subjects (as defined in Section 4, Subject Enrollment), Principal Investigator and any sub- investigators will complete the Pfizer-provided Good Clinical Practice training course (“Pfizer GCP Training”). Any investigators who later join the Study will complete the Pfizer GCP Training before performing Study-related duties. For studies of applicable duration, Principal Investigator and sub- sub-investigators will complete Pfizer GCP Training every three years during the term of the Study, or more often if there are significant changes to the ICH GCP guidelines or course materials.